18F-FDG PET	18Fluor-fluorodeoxyglucose positron emission tomography
ACE	Angiotensin-converting enzyme
AHA	American Heart Association
AIVR	Accelerated idioventricular rhythm
ALAT	Alanine aminotransferase
AVB	Atrioventricular block
BMI	Body mass index
cMRI	Cardiac magnetic resonance imaging
CRP	C-reactive protein
CS	Cardiac sarcoidosis
DPI	Dossier Patient Informatisé
ECG	Electrocardiogram
ENT	Ear, nose, and throat
ESR	Erythrocyte sedimentation rate
FDG	Fluorodeoxyglucose
(a)HR	(adjusted) Hazard ratio
HRS	Heart Rhythm Society
ICD	Implantable cardioverter–defibrillator
IQR	Interquartile range
IS	Immunosuppressive
JCS	Japanese Circulation Society
LA	Left atrium
LGE	Late gadolinium enhancement
LN	Lymph node
LV	Left ventricle
LVAD	Left ventricular assist device
LVEF	Left ventricular ejection fraction
MACE	Major adverse cardiac event
MMF	Mycophenolate mofetil
MRI	Magnetic resonance imaging
MTX	Methotrexate
NRG	Non-relapse group
NT-proBNP	N-terminal pro B-type natriuretic peptide
PET	Positron emission tomography
PVC	Premature ventricular contraction
RA	Right atrium
RBBB	Right bundle branch block
RG	Relapse group
RV	Right ventricle
S6K	S6 kinase
SUVmax	Maximum standardized uptake value
T2	T2-weighted imaging
TNF	Tumor necrosis factor
VF	Ventricular fibrillation
VT	Ventricular tachycardia